Posted in | News | Display

The Global TFT-LCD Panel Industry

Research and Markets has announced the addition of "TFT-LCD Panel Industry Development in Japan, China, Korea and Taiwan" to their offering.

Global TFT-LCD panel production capacity and the TFT-LCD supply chain are heavily concentrated in Taiwan, Korea, Japan, and China. In Japan, while Sharp continues to develop its TFT-LCD panel operations independently, other leading Japanese panel makers have jointly established IPS Alpha, in a bid to spread investment risk and ensure steady large-sized TFT-LCD panel supply. The Korean flat-panel display industry has been led by Samsung and LG. Philips, which have been expanding their large-sized TFT-LCD panel production capacity and establishing new production lines for larger substrates. In China, the government has been actively encouraging domestic and international corporations to invest in panel production in China through special incentive measures. In Taiwan, the government's Two Trillion, Twin Star industry plan has prompted the development of the large-sized TFT-LCD panel industry. This report will analyze the large-sized LCD panel industries in Japan, China, Korea, and Taiwan.

List of Topics

Flat panel display clusters and the flat panel display industry value chain in Japan, Taiwan, Korea, and China; comparison of the Japanese, Korean, Taiwanese, and Chinese flat panel display industries, including panel makers' production investment and capacity expansion plans; Japanese, Korean, Taiwanese, and Chinese panel makers' strategies for future development.

Companies mentioned:

  • Samsung
  • LG
  • Philips

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.